Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicines Including a 12 Week Extension and a 1 Year Open-label Extension Study.
Clinical trial NCT01080131 · COMPLETED
Trial details
- NCT number
- NCT01080131
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-03-01
- Primary completion
- 2010-11-01
- Enrollment
- 226
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.